Brevan Howard Capital Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Buy
36,063
+26,287
+269% +$1.61M 0.01% 762
2026
Q1
$638K Buy
+9,776
New +$715K 0.01% 1160
2024
Q4
– Sell
-7,250
Closed -$634K – 1136
2024
Q3
$634K Sell
7,250
-2,323
-24% -$196K ﹤0.01% 618
2024
Q2
$756K Buy
9,573
+5,669
+145% +$466K 0.01% 468
2024
Q1
$353K Buy
3,904
+1,362
+54% +$124K ﹤0.01% 594
2023
Q4
$223K Buy
+2,542
New +$212K ﹤0.01% 848

Other funds holding DOX

Brevan Howard Capital Management's DOX Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Amdocs (DOX) stake by 269% in Q2 2026, buying an estimated $1.61M and bringing the position to 36,063 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #762.

Brevan Howard Capital Management first reported a position in DOX in Q4 2023 and has held it in 6 quarters since. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Brevan Howard Capital Management held 36,063 shares of Amdocs worth $1.82M as of Q2 2026.
  • Brevan Howard Capital Management bought 26,287 Amdocs shares in Q2 2026, an estimated $1.61M.
  • Amdocs made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #762 holding.
  • Brevan Howard Capital Management first reported a position in Amdocs in Q4 2023 and has held it in 6 quarters since.
  • 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.